Determination of Drug Residence Time in an HTS Format using Kinetic Analysis with the Transcreener® ADP2 Assay
19 Jun 2016This poster describes a systematic approach to determine the residence time of compounds using Abl1 and Aurora C as targets and several well characterized ATP-competitive drugs. Residence time can be determined by equilibrium binding measurements using methods such as surface plasmon resonance (SPR), which provides highly quantitative data but requires costly instrumentation and long experimental timelines. Transcreener® ADP2 Assays offer a highly sensitive and versatile method for estimating drug residence times for kinases using a multimode fluorescent plate reader.
Related Products
Request Quote for All Products
Transcreener® ADP² Kinase Assays
BellBrook LabsThe Transcreener® ADP² Kinase Assay Kit universally detects ADP produced by any kinase or ATPase using a direct mix‑and‑read format, eliminating coupling steps. Available in FP, FI, and TR‑FRET formats with far‑red tracers to minimize interference, it's HTS-ready across 96‑, 384‑, and 1536‑well plates with robust Z' ≥ 0.7 performance.